Literature DB >> 9382020

Antimyosin scintigraphy for detection of cardiac amyloidosis.

J Lekakis1, M Dimopoulos, J Nanas, V Prassopoulos, N Agapitos, G Alexopoulos, L Palazis, P Kostamis, S Stamatelopoulos, S Moulopoulos.   

Abstract

The diagnostic value of antimyosin scanning in 7 patients with biopsy-proven cardiac amyloidosis was examined in this study. Antimyosin imaging was positive in all amyloid patients, with more intense uptake in patients with heart failure.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9382020     DOI： 10.1016/s0002-9149(97)00558-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  6 in total

1.  Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis.

Authors:  K Kodama; M Hamada; T Kuwahara; M Nakamura; Y Shigematsu; K Hiwada; T Iwata; Y Hoshii; T Ishihara
Journal:  Int J Card Imaging       Date:  1999-10

Review 2.  Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.

Authors:  Paco E Bravo; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

Review 3.  Molecular imaging of amyloidosis: will the heart be the next target after the brain?

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 4.  Nuclear imaging in cardiac amyloidosis.

Authors:  A W J M Glaudemans; R H J A Slart; C J Zeebregts; N C Veltman; R A Tio; B P C Hazenberg; R A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-21       Impact factor: 9.236

Review 5.  Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.

Authors:  Yiu Ming Khor; Sarah Cuddy; Rodney H Falk; Sharmila Dorbala
Journal:  Semin Nucl Med       Date:  2020-02-09       Impact factor: 4.802

Review 6.  Nuclear imaging of amyloidosis.

Authors:  Wojciech Cytawa; Jacek Teodorczyk; Piotr Lass
Journal:  Pol J Radiol       Date:  2014-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.